Multiple positive lupus studies have been a bright spot in an otherwise dark year, according to a panel of experts summing up the presentations delivered at ACR Convergence 2020. Highlights from the meeting were the including a phase 2 RCT of iberdomide – a cereblon E3 ligase modulator with immunostimulatory activity – in active SLE. ...
Lupus trials bring good news in 2020
By Mardi Chapman
17 Nov 2020